2. Samuel Johnson

3.  Morphine, the prototypical opioid agonist, has long been known to relieve severe pain with remarkable efficacy. The opium poppy is the source of crude opium from which Serturner in 1803 isolated morphine, the pure alkaloid and named it after Morpheus, the Greek god of dreams. It remains the standard against which all drugs that have strong analgesic action are compared.

4. Opium, the source of morphine, is obtained from the poppy, Papaver somniferum. After incision, the poppy seed pod exudes a white substance that turns into a brown gum that is crude opium. Opium contains many alkaloids, the principle one being morphine, which is present in a concentration of about 10%. Codeine is synthesized commercially from morphine.

5. “opium” is a Greek word meaning “juice,” or the exudates from the poppy ( Papaver (somniferum “opiate” is a drug extracted from the exudates of the poppy “opioid” is a natural or synthetic drug that binds to opioid receptors producing agonist effects

8.  Opioid Receptors:  Opioids interact specifically with protein receptors on the membranes of certain cells in the CNS, on nerve terminals in the periphery, and on cells of the gastrointestinal tract and other anatomic regions. The major effects of the opioids are mediated by three major receptor families. These are designated by the Greek letters (mu), (kappa), and (delta). Each receptor family exhibits a different specificity for the drug(s) it binds.

9. u (mu)  Supraspinal and spinal analgesia; sedation; inhibition of respiration; slowed GI transit; modulation of hormone and neurotransmitter release  d (delta) Supraspinal and spinal analgesia; modulation of hormone and neurotransmitter release.  k (kappa) Supraspinal and spinal analgesia; psychotomimetic effects; slowed GI transit

10.  : Morphine:  Organ systemic effects:  1. Central nervous system effects  The principal effects of opioid analgesics with affinity for Mu receptors are on the CNS; the more important ones include analgesia, euphoria, sedation, and respiratory depression. With repeated use, a high degree of tolerance occurs to all these effects

11.  a. Analgesia: Pain consists of both sensory and affective (emotional) components. Opioid analgesics are unique in that they can reduce both aspects of the pain experience, especially the affective aspect b. Euphoria: Typically, patients or intravenous drug users who receive intravenous morphine experience a pleasant floating sensation with lessened anxiety and distress

12.  c. Sedation: Drowsiness and clouding of mentation are common concomitants of opioid action. There is little or no amnesia. Sleep is induced by opioids more frequently in the elderly than in young, healthy individuals. Ordinarily, the patient can be easily aroused from this sleep. d. Respiratory depression: All of the opioid analgesics can produce significant respiratory depression by inhibiting brainstem respiratory mechanisms. The respiratory depression is dose- related and is influenced significantly by the degree of sensory input occurring at the time. Opioid- induced respiratory depression remains one of the most difficult clinical challenges in the treatment of severe pain.

13.  e. Cough suppression: Suppression of the cough reflex is a well-recognized action of opioids. Codeine in particular has been used to advantage in persons suffering from pathologic cough and in patients in whom it is necessary to maintain ventilation via an endotracheal tube..

14.  f. Miosis: Constriction of the pupils is seen with virtually all opioid agonists.  g. Truncal rigidity: An intensification of tone in the large trunk muscles has been noted with a number of opioids.. h. Nausea and vomiting: The opioid analgesics can activate the brainstem chemoreceptor trigger zone to produce nausea and vomiting.  i. Temperature: mu opioid receptor agonists such as morphine administered to the anterior hypothalamus produces hyperthermia, whereas administration of k agonists induce hypothermia.

16. Cardiovascular system: No effect Large dose: hypotension and bradycardia Increase the cerebrospinal fluid (CSF) pressure Gastrointestinal tract: Constipation Biliary tract: Biliary colic reflux of biliary and pancreatic secretions

17. Renal: Renal function is depressed by opioids. Uterus: The opioid analgesics may prolong labor. Neuroendocrine: Opioid analgesics stimulate the release of ADH, prolactin, and somatotropin but inhibit the release of luteinizing hormone.

18. Pruritus: Therapeutic doses of the opioid analgesics produce flushing and warming of the skin accompanied sometimes by sweating and itching; Miscellaneous: The opioids modulate the immune system by effects on lymphocyte proliferation, antibody production, and chemotaxis.

19.  Analgesia  Treatment of diarrhea  Relief of cough: codeine or dextromethorphan are more widely used for this purpose.  Treatment of acute pulmonary edema: 1. reduced anxiety 2. reduced cardiac preload 3. reduced after load

20. Absorption of morphine from the gastrointestinal tract is slow and erratic. Codeine, by contrast, is well absorbed when given by mouth. Significant first-pass metabolism of morphine occurs in the liver When used orally, morphine is commonly administered in an extended-release form

21. Distribution: Morphine rapidly enters all body tissues, including the fetuses of pregnant women. Infants born of addicted mothers show physical dependence on opiates and exhibit withdrawal symptoms if opioids are not administered. Only a small percentage of morphine crosses the blood- brain barrier.

22. Fate:  Morphine is conjugated in the liver to glucuronic acid. The conjugates are excreted primarily in the urine.  The duration of action of morphine is 4 to 6 hours when administered systemically but considerably longer when injected epidurally

23.  Severe respiratory depression.  Other effects include vomiting dysphoria, and allergy- enhanced hypotensive effects.  The elevation of intracranial pressure.  In benign prostatic hyperplasia, morphine may cause acute urinary retention.

24. Repeated use produces tolerance to the respiratory depressant, analgesic, euphoric, and sedative effects of morphine. However, tolerance usually does not develop to the pupil- constricting and constipating effects of the drug.

25. The depressant actions of morphine are enhanced by phenothiazines monoamine oxidase inhibitors tricyclic antidepressants

26. Codeine  The analgesic actions of codeine are due to its conversion to morphine.  codeine is a much less potent analgesic than morphine, but it has a higher oral effectiveness.   Codeine shows good antitussive activity.  It has a lower potential for abuse than morphine, and it rarely produces dependence.  Codeine produces less euphoria than morphine.

27.  Pentazocine Pentazocine acts as an agonist on kappa receptors and is a weak antagonist at mu and kappa receptors. Pentazocine is used to relieve moderate pain. Pentazocine produces less euphoria compared to morphine. In higher doses, the drug causes respiratory depression &constipation. High doses increase blood pressure and can cause hallucinations, nightmares, dysphoria, tachycardia, and dizziness.

28. Tramadol is a centrally acting analgesic that binds to the μ-opioid receptor. It weakly inhibits reuptake of norepinephrine and serotonin. It is used to manage moderate to moderately severe pain. Its respiratory-depressant activity is less than that of morphine. ADRs: Anaphylactoid reactions seizures

29. Naloxone Naloxone is used to reverse the coma and respiratory depression of opioid overdose. Naloxone has a half-life of 60 to 100 minutes. Naloxone is a competitive antagonist at mu, kappa, and delta, receptors, with a 10-fold higher affinity for mu than for kappa receptors

30. Naltrexone has actions similar to those of naloxone. It has a longer duration of action than naloxone,

31. 1. Persistent activation of u receptors such as occurs with the treatment of severe chronic pain 2. Repeated exposure to agonist caused u receptors to be down-regulated by endocytosis. 3. Tolerance is due to a dysfunction of structural interactions between the u receptor and G proteins, second-messenger systems, and their target ion channels. 4. NMDA receptor, has been shown to play a critical role in tolerance development and maintenance

32. Which of the following statements about morphine is correct?  A. It is used therapeutically to relieve pain caused by severe head injury.  B. Its withdrawal symptoms can be relieved by naloxone.  C. It causes diarrhea.  D. It is most effective by oral administration.  E. It rapidly enters all body tissues, including the fetus.